Keith A B, Arnon R, Teitelbaum D, Caspary E A, Wisniewski H M
J Neurol Sci. 1979 Jul;42(2):267-74. doi: 10.1016/0022-510x(79)90058-3.
Cop 1, a synthetic polypeptide, was evaluated for its effect on a chronic relapsing form of experimental allergic encephalomyelitis (EAE). Pretreatment of juvenile Strain 13 guinea pigs with Cop 1 in incomplete Freund's adjuvant (IFA) which were subsequently challenged with guinea pig spinal cord in complete Freund's adjuvant (CFA) had a marked effect in delaying or preventing the appearance of clinical signs of EAE. Administration of Cop 1 on appearance of clinical signs of EAE prevented progression of the first episode of the disease. Although relapses were not always prevented, they were modified on their duration and intensity both clinically and histologically.
合成多肽Cop 1针对实验性变应性脑脊髓炎(EAE)的慢性复发性形式的作用进行了评估。用不完全弗氏佐剂(IFA)中的Cop 1对幼年13号品系豚鼠进行预处理,随后用完全弗氏佐剂(CFA)中的豚鼠脊髓进行攻击,这对延迟或预防EAE临床症状的出现具有显著作用。在EAE临床症状出现时给予Cop 1可阻止疾病首次发作的进展。虽然复发并非总能预防,但在临床和组织学上,其持续时间和强度均得到了改善。